POINT Biopharma Global Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
POINT Biopharma Global Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2023.
  • POINT Biopharma Global Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2023 was 107M shares, a 0.88% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 107M +924K +0.88% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 106M +15.6M +17.4% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 106M +15.6M +17.3% Mar 22, 2023 10-K 2023-03-27
Q3 2022 106M +15.5M +17.2% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 90.1M +3.17K +0% Aug 8, 2022 10-Q 2022-08-12
Q1 2022 90.1M Mar 21, 2022 10-K 2022-03-25
Q3 2021 90.1M Nov 8, 2021 10-Q 2021-11-12
Q2 2021 90.1M Aug 9, 2021 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.